Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Bulky dna adducts in cord blood, maternal fruit-and-vegetable consumption, and birth weight in a European mother-child study (NewGeneris)

  • Pedersen, Marie
  • Sunyer Deu, Jordi
  • Mendez, Michelle A.
  • Espinosa, Aina
  • Agramunt, Silvia
  • Kogevinas, Manolis
Background: Tobacco-smoke, airborne, and dietary exposures to polycyclic aromatic hydrocarbons (PAHs) have been associated with reduced prenatal growth. Evidence from biomarker-based studies of low-exposed populations is limited. Bulky DNA adducts in cord blood reflect the prenatal effective dose to several genotoxic agents including PAHs. Objectives: We estimated the association between bulky DNA adduct levels and birth weight in a multicenter study and examined modification of this association by maternal intake of fruits and vegetables during pregnancy. Methods: Pregnant women from Denmark, England, Greece, Norway, and Spain were recruited in 2006–2010. Adduct levels were measured by the 32P-postlabeling technique in white blood cells from 229 mothers and 612 newborns. Maternal diet was examined through questionnaires. Results: Adduct levels in maternal and cord blood samples were similar and positively correlated (median, 12.1 vs. 11.4 adducts in 108 nucleotides; Spearman rank correlation coefficient = 0.66, p < 0.001). Cord blood adduct levels were negatively associated with birth weight, with an estimated difference in mean birth weight of –129 g (95% CI: –233, –25 g) for infants in the highest versus lowest tertile of adducts. The negative association with birth weight was limited to births in Norway, Denmark, and England, the countries with the lowest adduct levels, and was more pronounced in births to mothers with low intake of fruits and vegetables (–248 g; 95% CI: –405, –92 g) compared with those with high intake (–58 g; 95% CI: –206, 90 g). Conclusions: Maternal exposure to genotoxic agents that induce the formation of bulky DNA adducts may affect intrauterine growth. Maternal fruit and vegetable consumption may be protective., The NewGeneris (Newborns and Genotoxic exposure risks) study was funded by the European Union (EU contract FOOD-CT-2005-016320). The study/nwas also supported by the National Institute for Health Research, United Kingdom (programme grant RP-PG-0407-10044), the Norwegian Ministry of/nHealth, the Norwegian Ministry of Education and Research, the Norwegian Research Council/FUGE (grant 151918/S10), the EU funded HiWATE (contract Food-CT-2006-036224), the U.S. National Institutes of Health (NIH)/National Institute of Environmental Health Sciences (contract NO-ES-75558), and the U.S. NIH/National Institute of Neurological Disorders and Stroke (grant 1 UO1 NS 047537-01). M.P. holds a Juan de la Cierva postdoctoral fellowship awarded from the Spanish Ministry of Science and Innovation (JCI-2011-09479)
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

In utero exposure to dioxins and dioxin-like compounds and anogenital distance in newborns and infants

  • Vafeiadi, Marina, 1983-
  • Agramunt, Silvia
  • Papadopoulou, Eleni, 1985-
  • Besselink, Harrie
  • Mathianaki, Kleopatra
  • Karakosta, Polyxeni
  • Spanaki, Ariana
  • Koutis, Antonis
  • Chatzi, Leda
  • Vrijheid, Martine
  • Kogevinas, Manolis
BACKGROUND: Anogenital distance in animals is used as a measure of fetal androgen action. Prenatal exposure to dioxins and dioxin-like compounds in rodents causes reproductive changes in male offspring and decreases anogenital distance. OBJECTIVE: We assessed whether in utero exposure to dioxins and dioxin-like compounds adversely influences anogenital distance in newborns and young children (median age, 16 months; range, 1-31 months) METHODS: We measured anogenital distance among participants of the "Rhea" mother-child cohort study in Crete and the Hospital del Mar (HMAR) cohort in Barcelona. Anogenital distance (AGD; anus to upper penis), anoscrotal distance (ASD; anus to scrotum), and penis width (PW) were measured in 119 newborn and 239 young boys; anoclitoral (ACD; anus to clitoris) and anofourchetal distance (AFD; anus to fourchette) were measured in 118 newborn and 223 young girls. We estimated plasma dioxin-like activity in maternal blood samples collected at delivery with the Dioxin-Responsive Chemically Activated LUciferase eXpression (DR CALUX®) bioassay. RESULTS: Anogenital distances were sexually dimorphic, being longer in males than females. Plasma dioxin-like activity was negatively associated with AGD in male newborns. The estimated change in AGD per 10 pg CALUX®-toxic equivalent/g lipid increase was -0.44 mm (95% CI: -0.80, -0.08) after adjusting for confounders. Negative but smaller and nonsignificant associations were observed for AGD in young boys. No associations were found in girls. CONCLUSIONS: Male infants may be susceptible to endocrine-disrupting effects of dioxins. Our findings are consistent with the experimental animal evidence used by the Food and Agriculture Organization/World Health Organization to set recommendations for human dioxin intake., This study was partly funded by FP6 and FP7 European Union grants (contract number FOOD-CT-2005-016320 and 241604 respectively)
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: the NewGeneris cohort

  • Merlo, Domenico Franco
  • Agramunt, Silvia
  • Kogevinas, Manolis
  • Pedersen, Marie
  • Delft, Joost H.M. van
  • NewGeneris Consortium
Background: Leukemia incidence has increased in recent decades among European children, suggesting that early-life environmental exposures play an important role in disease development. Objectives: We investigated the hypothesis that childhood susceptibility may increase as a result of in utero exposure to carcinogens and hormonally acting factors. Using cord blood samples from the NewGeneris cohort, we examined associations between a range of biomarkers of carcinogen exposure and hormonally acting factors with micronuclei (MN) frequency as a proxy measure of cancer risk. Associations with gene expression and genotype were also explored. Methods: DNA and protein adducts, gene expression profiles, circulating hormonally acting factors, and GWAS (genome-wide association study) data were investigated in relation to genomic damage measured by MN frequency in lymphocytes from 623 newborns enrolled between 2006 and 2010 across Europe. Results: Malondialdehyde DNA adducts (M1dG) were associated with increased MN frequency in binucleated lymphocytes (MNBN), and exposure to androgenic, estrogenic, and dioxin-like compounds was associated with MN frequency in mononucleated lymphocytes (MNMONO), although no monotonic exposure–outcome relationship was observed. Lower frequencies of MNBN were associated with a 1-unit increase expression of PDCD11, LATS2, TRIM13, CD28, SMC1A, IL7R, and NIPBL genes. Gene expression was significantly higher in association with the highest versus lowest category of bulky and M1dG–DNA adducts for five and six genes, respectively. Gene expression levels were significantly lower for 11 genes in association with the highest versus lowest category of plasma AR CALUX® (chemically activated luciferase expression for androgens) (8 genes), ERα CALUX® (for estrogens) (2 genes), and DR CALUX® (for dioxins). Several SNPs (single-nucleotide polymorphisms) on chromosome 11 near FOLH1 significantly modified associations between androgen activity and MNBN frequency. Polymorphisms in EPHX1/2 and CYP2E1 were associated with MNBN. Conclusion: We measured in utero exposure to selected environmental carcinogens and circulating hormonally acting factors and detected associations with MN frequency in newborns circulating T lymphocytes. The results highlight mechanisms that may contribute to carcinogen-induced leukemia and require further research., This work was supported by the European Union (EU) Integrated Project “Newborns and Genotoxic exposure risks; NewGeneris,” 6th Framework Programme, Priority 5: Food Quality and Safety [FOOD-CT-2005-016320]. The study was also supported by grants obtained locally, including the National Institute for Health Research, UK (Programme grant RP-PG-0407-10044), the Norwegian Ministry of Health, the Norwegian Ministry of Education and Research, the Norwegian Research Council/FUGE (grant 151918/S10), and the EU-funded HiWATE (Health impacts of long-term exposure to disinfection by-products in drinking water; contract Food-CT-2006-036224)
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Birth weight, head circumference, and prenatal exposure to acrylamide from maternal diet: The European prospective mother-child study (NewGeneris)

  • Sunyer Deu, Jordi
  • Pedersen, Marie
  • Stedingk, Hans von
  • Botsivali, Maria
  • Agramunt, Silvia
  • Alexander, Jan
  • Brunborg, Gunnar
  • Chatzi, Leda
  • Fleming, Sarah
  • Fthenou, Eleni
  • Granum, Berit
  • Gutzkow, Kristine B.
  • Hardie, Laura J.
  • Knudsen, Lisbeth E.
  • Kyrtopoulos, Sosterios A.
  • Mendez, Michelle A.
  • Merlo, Domenico Franco
  • Nielsen, Jeanette K.
  • Rydberg, Per
  • Segerbäck, Dan
  • Wright, John
  • Törnqvist, Margareta
  • Kleinjans, Jos C.
  • Kogevinas, Manolis
  • NewGeneris Consortium
Background: Acrylamide is a common dietary exposure that crosses the human placenta. It is classified as a probable human carcinogen, and developmental toxicity has been observed in rodents. Objectives: We examined the associations between prenatal exposure to acrylamide and birth outcomes in a prospective European mother–child study. Methods: Hemoglobin (Hb) adducts of acrylamide and its metabolite glycidamide were measured in cord blood (reflecting cumulated exposure in the last months of pregnancy) from 1,101 singleton pregnant women recruited in Denmark, England, Greece, Norway, and Spain during 2006–2010. Maternal diet was estimated through food-frequency questionnaires. Results: Both acrylamide and glycidamide Hb adducts were associated with a statistically significant reduction in birth weight and head circumference. The estimated difference in birth weight for infants in the highest versus lowest quartile of acrylamide Hb adduct levels after adjusting for gestational age and country was –132 g (95% CI: –207, –56); the corresponding difference for head circumference was –0.33 cm (95% CI: –0.61, –0.06). Findings were similar in infants of nonsmokers, were consistent across countries, and remained after adjustment for factors associated with reduced birth weight. Maternal consumption of foods rich in acrylamide, such as fried potatoes, was associated with cord blood acrylamide adduct levels and with reduced birth weight. Conclusions: Dietary exposure to acrylamide was associated with reduced birth weight and head circumference. Consumption of specific foods during pregnancy was associated with higher acrylamide exposure in utero. If confirmed, these findings suggest that dietary intake of acrylamide should be reduced among pregnant women., The NewGeneris (Newborns and Genotoxic exposure risks) study was funded by the European Union (EU Contract FOOD-CT-2005-016320). The study was also supported by grants obtained locally, including the Swedish Cancer and Allergy Foundation and the Swedish Research Council Formas, the National Institute for Health Research, UK (programme grant RP-PG-0407-10044), the Norwegian Ministry of Health, the Norwegian Ministry of Education and Research, the Norwegian Research Council/FUGE (grant 151918/S10), the EU funded HiWATE (contract Food-CT-2006-036224), the U.S. National Institutes of Health (NIH)/National Institute of Environmental Health Sciences (contract NO-ES-75558), and the U.S. NIH/National Institute of Neurological Disorders and Stroke (grant 1 UO1 NS 047537-01). M.P. holds a Juan de la Cierva postdoctoral fellowship awarded from the Spanish Ministry of Science and Innovation (JCI-2011-09479)
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

The hCOMET Project: International Database Comparison of Results with the Comet Assay in Human Biomonitoring. Baseline Frequency of DNA Damage and Effect of Main Confounders

  • Milić, Mirta
  • Ceppi, Marcello
  • Bruzzone, Marco
  • Azqueta, Amaya
  • Brunborg, Gunnar
  • Godschalk, Roger
  • Koppen, Gudrun
  • Langie, Sabine
  • Møller, Peter
  • Alija, Avdulla
  • Anderson, Diana
  • Andreoli, Cristina
  • Asllani, Fisnik
  • Boutet-Robinet, Elisa
  • Buschini, Annamaria
  • Cavallo, Delia
  • Costa, Solange
  • Da Silva, Juliana
  • Del Bo’, Cristian
  • Djelić, Ninoslav
  • Dobrzyńska, Malgorzata
  • Dvořáková, Monika
  • Gajski, Goran
  • Galati, Serena
  • García Lima, Omar
  • Giovannelli, Lisa
  • Goroshinskaya, Irina A.
  • Grindel, Annemarie
  • Hernández, Alba
  • Hernández, Carlos
  • Holven, Kirsten B.
  • Ibero-Baraibar, Idoia
  • Ottestad, Inger
  • Kadioglu, Ela
  • Kuznetsova, Elena
  • Ladeira, Carina
  • Laffon, Blanca
  • Lamonaca, Palma
  • Lebailly, Pierre
  • Louro, Henriqueta
  • Mandina Cardoso, Tania
  • Marcon, Francesca
  • Marcos, Ricard
  • Moretti, Massimo
  • Moretti, Silvia
  • Najafzadeh, Mojgan
  • Nemeth, Zsuzsanna
  • Neri, Monica
  • Novotna, Bozena
  • Orlow, Irene
  • Paduchova, Zuzana
  • Pastor, Susana
  • Perdry, Hervé
  • Spremo-Potparević, Biljana
  • Ramadhani, Dwi
  • Riso, Patrizia
  • Rohr, Paula
  • Rojas, Emilio
  • Rossner, Pavel
  • Sardas, Semra
  • Silva, Maria João
  • Sirota, Nikolay
  • Smolkova, Bozena
  • Staruchova, Marta
  • Stetina, Rudolf
  • Stopper, Helga
  • Ursini, Cinzia Lucia
  • Valdiglesias, Vanessa
  • Valverde, Mahara
  • Volkovova, Katarina
  • Wagner, Karl-Heinz
  • Živković, Lada
  • Dusinska, Maria
  • Collins, Andrew
  • Bonassi, Stefano
  • Teixeira, Joao
  • Andrade, Vanessa Moraes de
  • Bankoglu, Ezgi Eylül
  • Barančoková, Magdaléna
  • Pereira, Cristiana
  • Dimitrijević-Srećković, Vesna
  • Sáfár, Anna
  • Surikova, Ekaterina
  • Vodička, Pavel
  • Başaran, Nurşen
  • Costa, C.
  • Ďuračková, Zdeňka
  • Kažimírová, Alena
  • Gützkow, Kristine Bjerve
  • Ulven, Stine Marie
[Abstract] The alkaline comet assay, or single cell gel electrophoresis, is one of the most popular methods for assessing DNA damage in human population. One of the open issues concerning this assay is the identification of those factors that can explain the large inter-individual and inter-laboratory variation. International collaborative initiatives such as the hCOMET project - a COST Action launched in 2016 - represent a valuable tool to meet this challenge. The aims of hCOMET were to establish reference values for the level of DNA damage in humans, to investigate the effect of host factors, lifestyle and exposure to genotoxic agents, and to compare different sources of assay variability. A database of 19,320 subjects was generated, pooling data from 105 studies run by 44 laboratories in 26 countries between 1999 and 2019. A mixed random effect log-linear model, in parallel with a classic meta-analysis, was applied to take into account the extensive heterogeneity of data, due to descriptor, specimen and protocol variability. As a result of this analysis interquartile intervals of DNA strand breaks (which includes alkali-labile sites) were reported for tail intensity, tail length, and tail moment (comet assay descriptors). A small variation by age was reported in some datasets, suggesting higher DNA damage in oldest age-classes, while no effect could be shown for sex or smoking habit, although the lack of data on heavy smokers has still to be considered. Finally, highly significant differences in DNA damage were found for most exposures investigated in specific studies. In conclusion, these data, which confirm that DNA damage measured by the comet assay is an excellent biomarker of exposure in several conditions, may contribute to improving the quality of study design and to the standardization of results of the comet assay in human populations., This article is based upon work from COST Action hCOMET CA15132, supported by COST (European Cooperation in Science and Technology www.cost.eu) - STSM fellowships for Mirta Milić (IMROH, EU 19); IMROH, Zagreb, Croatia, Institute for Medical Research and Occupational Health (IMROH), Zagreb, Croatia, and the Ministry of Science, Education and Sports of the Republic of Croatia (Grant No. 022-0222148-2125) (EU4); Cancer Plan for PestiBG; Grant number: no ENV201401(EU 8, EU9); Italian Ministry of Education, University and Research PRIN 2005, prot. 2005058197 and Cariplo Foundation (Milan, Italy), Rif. Pratica 2007-5810 and Rif. Pratica 2010.2303 (EU 18); Associazione Italiana per la Ricerca sul Cancro (AIRC) (IG 2015/17564). (EU19); European Union Integrated Projects New Generis, 6th Framework Programme, Priority 5: Food Quality and Safety; Newborns and Genotoxic Exposure Risks, FOOD-CT-2005-016320 (EU22); ACT project No. 036APy/09 and No. 005DBB/12 (EU 24); FCT-SFRH/BPD/96196/2013, SFRH/BPD/100948/2014, Portugal (EU 26); MZ 2012/8-UKBA-8; VEGA 1/0703/13, APVV 15-0063 (EU30); Xunta de Galicia (XUGA 10605B98; INCITE08PXIB106155PR; ED481B2016/190-0; Grants ED431B2019/02), Spain (EU 32); Grant 01 173034, Ministry of Education, Science and Technological Development of the Republic of Serbia (EU 42); The Centre for Industrial and Technological Development within National Strategic Consortia for Techical Research (Industrial Research diets and food with specific characteristics for elderly, SENIFOOD); University of Navarra LE/97; Physiopathology of Obesity and Nutrition (CIBER Obn); Carlos III Health Research Institute (CB12/03/30002); Ministerio de Economia y Compatitividad (‘Ramón y Cajal’ Programme, RYC-2013-14370) of the Spanish Government for personal support (EU 45); the Ministry of Education, Youth and Sports of the Czech Republic project Healthy Aging in Industrial Environment HAIE (CZ.02.1.01/0.0/0.0/16_019/0000798) which is co-financed by the European Union (European Structural and Investment funds; Operation Programme Research, Development and Education); MYES LO 1508 (EU 46); MICRODIAB Study; ClinicalTrials.org (#NCT02231736) (EU 52); The study was funded by the Italian Ministry for Education, University and Scientific Research (MIUR) - Research No. 2005-062547 (EU14, EU53); Projects financed from Serbian Ministry of Education, Science and Technological Development #11146002, #175035, #173034 (EU 54); Mehr foundation organisation, UK (EU 55); MCTI/CNPQ No. 01/2016-Universal; FAPESC No. 09/2015; MEC/MCTI/CAPES/CNPQ/FAPS/ No. 09/2014, Brazil (CSA 6); the National Nuclear Energy Agency of Indonesia (Badan Tenaga Nuklir Nasional) with contract number 080.01.06 3447.001 001.052.A (AS4); Slovak Grant Agency (APVT-21 013202, APVT-21- 017704); Ministry of Health, Slovak Republic (2005/43-SZU-21, 2006/07- SZU-02 MZ SR, <GN21>2005/42-SZU-20</GN21), New Generis, 6th Framework Programme QLK4-CT-1999-01629 and ERBICI 15-CT96-1012, CIPA-CT94-0129. (EU31); R.G. and S.L. thank the European Network of Excellence (NoE) ‘Environmental Cancer risk, Nutrition and Individual Susceptibility’ (ECNIS), sixth Framework programme (FP6), FOOD-CT-2005-513943 for financial support (EU21)., Croacia. Ministarstvo znanosti i obrazovanja; 022-0222148-2125, Italia. Ministero dell'Istruzione, dell'Università e della Ricerca; 2005058197, Fondazione Cariplo (Milan); 2007-5810, Fondazione Cariplo (Milan); 2010.2303, Associazione Italiana per la Ricerca sul Cancro; IG 2015/17564, Xunta de Galicia; XUGA10605B98, Xunta de Galicia; INCITE08PXIB106155PR, Xunta de Galicia; ED481B2016/190-0, Xunta de Galicia; ED431B2019/02, Serbia. Ministry of Education, Science and Technological Development; 01 173034, República Checa. Ministerstvo školství, mládeže a tělovýchovy; CZ.02.1.01/0.0/0.0/16_019/0000798, Italia. Ministero dell'Istruzione, dell'Università e della Ricerca; 2005-062547, Brasil. Ministério da Ciência, Tecnologia e Inovação; 01/2016-Universal, Brasil. Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina (Fapesc); 09/2015, Indonesia. Badan Tenaga Nuklir Nasional; 080.01.06 3447.001 001.052.A, República Eslovaca. Agentúra na podporu výskumu a vývoja; APVT-21 013202, República Eslovaca. Agentúra na podporu výskumu a vývoja; APVT-21- 017704, República Eslovaca. Ministerstvo Zdravotníctva; 2005/43-SZU-21, República Eslovaca. Ministerstvo Zdravotníctva; 2006/07- SZU-02, República Eslovaca. Ministerstvo Zdravotníctva; 2005/42-SZU-20, Portugal. Autoridade para as Condições de Trabalho; 036APy/09, Portugal. Autoridade para as Condições de Trabalho; 005DBB/12, Portugal. Fundação para a Ciência e a Tecnologia; SFRH/BPD/96196/2013, Portugal. Fundação para a Ciência e a Tecnologia; SFRH/BPD/100948/2014, República Eslovaca. Ministerstvo Zdravotníctva; 2012/8-UKBA-8, República Eslovaca. Univerzita Komenského; VEGA 1/0703/13, República Eslovaca. Univerzita Komenského; APVV 15-0063, Serbia. Ministry of Education, Science and Technological Development; 11146002, Serbia. Ministry of Education, Science and Technological Development; 175035, Brasil. Ministério da Ciência, Tecnologia e Inovações; 09/2014
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: the NewGeneris cohort

  • Merlo, Domenico Franco
  • Agramunt, Silvia
  • Kogevinas, Manolis
  • Pedersen, Marie
  • Delft, Joost H.M. van
  • NewGeneris Consortium
Background: Leukemia incidence has increased in recent decades among European children, suggesting that early-life environmental exposures play an important role in disease development. Objectives: We investigated the hypothesis that childhood susceptibility may increase as a result of in utero exposure to carcinogens and hormonally acting factors. Using cord blood samples from the NewGeneris cohort, we examined associations between a range of biomarkers of carcinogen exposure and hormonally acting factors with micronuclei (MN) frequency as a proxy measure of cancer risk. Associations with gene expression and genotype were also explored. Methods: DNA and protein adducts, gene expression profiles, circulating hormonally acting factors, and GWAS (genome-wide association study) data were investigated in relation to genomic damage measured by MN frequency in lymphocytes from 623 newborns enrolled between 2006 and 2010 across Europe. Results: Malondialdehyde DNA adducts (M1dG) were associated with increased MN frequency in binucleated lymphocytes (MNBN), and exposure to androgenic, estrogenic, and dioxin-like compounds was associated with MN frequency in mononucleated lymphocytes (MNMONO), although no monotonic exposure–outcome relationship was observed. Lower frequencies of MNBN were associated with a 1-unit increase expression of PDCD11, LATS2, TRIM13, CD28, SMC1A, IL7R, and NIPBL genes. Gene expression was significantly higher in association with the highest versus lowest category of bulky and M1dG–DNA adducts for five and six genes, respectively. Gene expression levels were significantly lower for 11 genes in association with the highest versus lowest category of plasma AR CALUX® (chemically activated luciferase expression for androgens) (8 genes), ERα CALUX® (for estrogens) (2 genes), and DR CALUX® (for dioxins). Several SNPs (single-nucleotide polymorphisms) on chromosome 11 near FOLH1 significantly modified associations between androgen activity and MNBN frequency. Polymorphisms in EPHX1/2 and CYP2E1 were associated with MNBN. Conclusion: We measured in utero exposure to selected environmental carcinogens and circulating hormonally acting factors and detected associations with MN frequency in newborns circulating T lymphocytes. The results highlight mechanisms that may contribute to carcinogen-induced leukemia and require further research., This work was supported by the European Union (EU) Integrated Project “Newborns and Genotoxic exposure risks; NewGeneris,” 6th Framework Programme, Priority 5: Food Quality and Safety [FOOD-CT-2005-016320]. The study was also supported by grants obtained locally, including the National Institute for Health Research, UK (Programme grant RP-PG-0407-10044), the Norwegian Ministry of Health, the Norwegian Ministry of Education and Research, the Norwegian Research Council/FUGE (grant 151918/S10), and the EU-funded HiWATE (Health impacts of long-term exposure to disinfection by-products in drinking water; contract Food-CT-2006-036224)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Bulky dna adducts in cord blood, maternal fruit-and-vegetable consumption, and birth weight in a European mother-child study (NewGeneris)

  • Pedersen, Marie
  • Sunyer Deu, Jordi
  • Mendez, Michelle A.
  • Espinosa, Aina
  • Agramunt, Silvia
  • Kogevinas, Manolis
Background: Tobacco-smoke, airborne, and dietary exposures to polycyclic aromatic hydrocarbons (PAHs) have been associated with reduced prenatal growth. Evidence from biomarker-based studies of low-exposed populations is limited. Bulky DNA adducts in cord blood reflect the prenatal effective dose to several genotoxic agents including PAHs. Objectives: We estimated the association between bulky DNA adduct levels and birth weight in a multicenter study and examined modification of this association by maternal intake of fruits and vegetables during pregnancy. Methods: Pregnant women from Denmark, England, Greece, Norway, and Spain were recruited in 2006–2010. Adduct levels were measured by the 32P-postlabeling technique in white blood cells from 229 mothers and 612 newborns. Maternal diet was examined through questionnaires. Results: Adduct levels in maternal and cord blood samples were similar and positively correlated (median, 12.1 vs. 11.4 adducts in 108 nucleotides; Spearman rank correlation coefficient = 0.66, p < 0.001). Cord blood adduct levels were negatively associated with birth weight, with an estimated difference in mean birth weight of –129 g (95% CI: –233, –25 g) for infants in the highest versus lowest tertile of adducts. The negative association with birth weight was limited to births in Norway, Denmark, and England, the countries with the lowest adduct levels, and was more pronounced in births to mothers with low intake of fruits and vegetables (–248 g; 95% CI: –405, –92 g) compared with those with high intake (–58 g; 95% CI: –206, 90 g). Conclusions: Maternal exposure to genotoxic agents that induce the formation of bulky DNA adducts may affect intrauterine growth. Maternal fruit and vegetable consumption may be protective., The NewGeneris (Newborns and Genotoxic exposure risks) study was funded by the European Union (EU contract FOOD-CT-2005-016320). The study/nwas also supported by the National Institute for Health Research, United Kingdom (programme grant RP-PG-0407-10044), the Norwegian Ministry of/nHealth, the Norwegian Ministry of Education and Research, the Norwegian Research Council/FUGE (grant 151918/S10), the EU funded HiWATE (contract Food-CT-2006-036224), the U.S. National Institutes of Health (NIH)/National Institute of Environmental Health Sciences (contract NO-ES-75558), and the U.S. NIH/National Institute of Neurological Disorders and Stroke (grant 1 UO1 NS 047537-01). M.P. holds a Juan de la Cierva postdoctoral fellowship awarded from the Spanish Ministry of Science and Innovation (JCI-2011-09479)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

In utero exposure to dioxins and dioxin-like compounds and anogenital distance in newborns and infants

  • Vafeiadi, Marina, 1983-
  • Agramunt, Silvia
  • Papadopoulou, Eleni, 1985-
  • Besselink, Harrie
  • Mathianaki, Kleopatra
  • Karakosta, Polyxeni
  • Spanaki, Ariana
  • Koutis, Antonis
  • Chatzi, Leda
  • Vrijheid, Martine
  • Kogevinas, Manolis
BACKGROUND: Anogenital distance in animals is used as a measure of fetal androgen action. Prenatal exposure to dioxins and dioxin-like compounds in rodents causes reproductive changes in male offspring and decreases anogenital distance. OBJECTIVE: We assessed whether in utero exposure to dioxins and dioxin-like compounds adversely influences anogenital distance in newborns and young children (median age, 16 months; range, 1-31 months) METHODS: We measured anogenital distance among participants of the "Rhea" mother-child cohort study in Crete and the Hospital del Mar (HMAR) cohort in Barcelona. Anogenital distance (AGD; anus to upper penis), anoscrotal distance (ASD; anus to scrotum), and penis width (PW) were measured in 119 newborn and 239 young boys; anoclitoral (ACD; anus to clitoris) and anofourchetal distance (AFD; anus to fourchette) were measured in 118 newborn and 223 young girls. We estimated plasma dioxin-like activity in maternal blood samples collected at delivery with the Dioxin-Responsive Chemically Activated LUciferase eXpression (DR CALUX®) bioassay. RESULTS: Anogenital distances were sexually dimorphic, being longer in males than females. Plasma dioxin-like activity was negatively associated with AGD in male newborns. The estimated change in AGD per 10 pg CALUX®-toxic equivalent/g lipid increase was -0.44 mm (95% CI: -0.80, -0.08) after adjusting for confounders. Negative but smaller and nonsignificant associations were observed for AGD in young boys. No associations were found in girls. CONCLUSIONS: Male infants may be susceptible to endocrine-disrupting effects of dioxins. Our findings are consistent with the experimental animal evidence used by the Food and Agriculture Organization/World Health Organization to set recommendations for human dioxin intake., This study was partly funded by FP6 and FP7 European Union grants (contract number FOOD-CT-2005-016320 and 241604 respectively)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Birth weight, head circumference, and prenatal exposure to acrylamide from maternal diet: The European prospective mother-child study (NewGeneris)

  • Sunyer Deu, Jordi
  • Pedersen, Marie
  • Stedingk, Hans von
  • Botsivali, Maria
  • Agramunt, Silvia
  • Alexander, Jan
  • Brunborg, Gunnar
  • Chatzi, Leda
  • Fleming, Sarah
  • Fthenou, Eleni
  • Granum, Berit
  • Gutzkow, Kristine B.
  • Hardie, Laura J.
  • Knudsen, Lisbeth E.
  • Kyrtopoulos, Sosterios A.
  • Mendez, Michelle A.
  • Merlo, Domenico Franco
  • Nielsen, Jeanette K.
  • Rydberg, Per
  • Segerbäck, Dan
  • Wright, John
  • Törnqvist, Margareta
  • Kleinjans, Jos C.
  • Kogevinas, Manolis
  • NewGeneris Consortium
Background: Acrylamide is a common dietary exposure that crosses the human placenta. It is classified as a probable human carcinogen, and developmental toxicity has been observed in rodents. Objectives: We examined the associations between prenatal exposure to acrylamide and birth outcomes in a prospective European mother–child study. Methods: Hemoglobin (Hb) adducts of acrylamide and its metabolite glycidamide were measured in cord blood (reflecting cumulated exposure in the last months of pregnancy) from 1,101 singleton pregnant women recruited in Denmark, England, Greece, Norway, and Spain during 2006–2010. Maternal diet was estimated through food-frequency questionnaires. Results: Both acrylamide and glycidamide Hb adducts were associated with a statistically significant reduction in birth weight and head circumference. The estimated difference in birth weight for infants in the highest versus lowest quartile of acrylamide Hb adduct levels after adjusting for gestational age and country was –132 g (95% CI: –207, –56); the corresponding difference for head circumference was –0.33 cm (95% CI: –0.61, –0.06). Findings were similar in infants of nonsmokers, were consistent across countries, and remained after adjustment for factors associated with reduced birth weight. Maternal consumption of foods rich in acrylamide, such as fried potatoes, was associated with cord blood acrylamide adduct levels and with reduced birth weight. Conclusions: Dietary exposure to acrylamide was associated with reduced birth weight and head circumference. Consumption of specific foods during pregnancy was associated with higher acrylamide exposure in utero. If confirmed, these findings suggest that dietary intake of acrylamide should be reduced among pregnant women., The NewGeneris (Newborns and Genotoxic exposure risks) study was funded by the European Union (EU Contract FOOD-CT-2005-016320). The study was also supported by grants obtained locally, including the Swedish Cancer and Allergy Foundation and the Swedish Research Council Formas, the National Institute for Health Research, UK (programme grant RP-PG-0407-10044), the Norwegian Ministry of Health, the Norwegian Ministry of Education and Research, the Norwegian Research Council/FUGE (grant 151918/S10), the EU funded HiWATE (contract Food-CT-2006-036224), the U.S. National Institutes of Health (NIH)/National Institute of Environmental Health Sciences (contract NO-ES-75558), and the U.S. NIH/National Institute of Neurological Disorders and Stroke (grant 1 UO1 NS 047537-01). M.P. holds a Juan de la Cierva postdoctoral fellowship awarded from the Spanish Ministry of Science and Innovation (JCI-2011-09479)